Built for Health Care M&A.
Driven by Results.

With nearly 400 successful transactions completed since 1998 and a top-five national ranking by the London Stock Exchange Group (LSEG) (formerly Thomson Reuters) for the past 15 years, our experience isn’t just measured in time; it’s defined by results.

We've partnered with over 94 private equity sponsors and have been recognized five times for excellence in health care dealmaking by the M&A Advisor. 

Trusted by hundreds of owners and executives, from independent providers to major publicly traded companies like Walgreens, Amedisys, and Addus HomeCare in divesting certain holdings, we’ve executed transactions from $5M to well over $500M in value.

Simply put, our experience enables us to deliver exceptional results across the board.

Behind every great deal is great data. With over 2400 health care valuation comps in our proprietary database, we equip our prospects and clients with unmatched insight into market trends, valuation, and timing.

Based on every client we’ve ever represented, we’ve created a rich database of client performance benchmarks, allowing us to quickly pinpoint strengths, address vulnerabilities, and guide strategic decisions. 

Our offering memoranda are also data-driven. By focusing on financial, operational, clinical, and utilization data, we ensure that offers are extremely well-informed, minimizing the risk of arbitrary price cuts before closing.

In an industry where conflicts of interest are common, we’ve built our reputation on doing things differently—by putting sellers first, always.

At The Braff Group, our unwavering commitment to trust is foundational. Unlike many brokers and investment banks that juggle multiple roles, we focus solely on representing sellers. We never accept fees from buyers, lenders, or other external parties to ensure our advice is free from conflicts of interest. 

This singular dedication to the sell-side may sometimes mean passing on immediate opportunities, but we believe that prioritizing our clients' best interests builds lasting relationships and confidence. 

When it comes to selling a business, timing and fit are everything. That’s why we never rush the process—because the right deal, at the right time, with the right buyer, is always worth the wait.

Patience is at the heart of our approach. We understand that our clients’ confidence in their decisions stems from a complete exploration of all options, including the choice not to sell. We don't rush to engage with a few "serial" buyers; instead, we diligently assess a broad spectrum of potential buyers to ensure the best fit for your company. Even when a lead buyer emerges, we continue to explore additional options to provide context and backup opportunities. 

We avoid "pre-emptive" offers that prematurely close the market and sacrifice negotiation leverage. Our commitment to patience ensures that we are thoughtful advocates, guiding our clients through a well-considered and strategic decision-making process.

When it comes to maximizing value, the best outcomes rarely come from following the crowd. Instead, they come from rethinking the playbook.

Creativity is embedded in The Braff Group's DNA. We challenge the status quo by consistently seeking innovative strategies that give our clients a competitive edge. Our approach includes developing strong backup buyers alongside the lead acquirer, providing sustained negotiating leverage, and seamless transitions when needed. 

We employ behavioral economics techniques, like anchor pricing, to motivate buyers to stretch and maximize price.  In addition, where appropriate, we use pricing collars to mitigate buyers’ incentives to challenge earnings during due diligence.

In summary, we never forget that every client and transaction is unique, demanding fresh thinking and creative solutions for each engagement.